AI Summary & Key Takeaways
AI InsightIn this case, we present the results of immunohistological analyses that was done to evaluate the origin of the metastatic lesions of a 48 years old woman who had a diagnosis of primary mucinous tumor and pseudomyxoma peritonei, also treatment method that was chosen by the help of these findings
📌 3 Key Takeaways
Abstract
Adenocarcinoma of the appendix is a rare neoplasm and constitutes <0,5% of all gastrointestinal neoplasms. There is no symptom of appendiceal cancer, and it is very difficult to diagnose preoperatively. Second primary synchronous and metachronous neoplasms, especially in the gastrointestinal tract, are found in up to 35% of patients with appendix adenocarcinoma. In this case, we present the results of immunohistological analyses that was done to evaluate the origin of the metastatic lesions of a 48 years old woman who had a diagnosis of primary mucinous tumor and pseudomyxoma peritonei, also treatment method that was chosen by the help of these findings
Özet
Appendiks adenokarsinomu tüm gastrointestinal tümörler içinde %0,5ten az bir orana sahip nadir bir antitedir. Preoperatif tanısı oldukça zor olması, spesifik semptomların olmamasına bağlıdır. Özellikle gastrointestinal orjinli olarak, ikinci primer senkron ve metakron neoplazmlar appendiks adenokarsinomlu hastaların %35inden fazlasında görülmektedir. Ovaryan tümörlerle senkron appendiks tümörlerinde primer odağın saptanması oldukça zordur. Bu olgu sunumunda over ve appendikste senkronize primer müsinöz tümörü ve pseudomiksoma peritonei tanısı alan 48 yaşındaki hastada, metastatik lezyonların orjinini tespite yönelik olarak yapılan immünohistokimyasal analiz sonuçları ve bu bulgulara göre belirlenen adjuvan tedavi metodu sunulmaktadır.